BridgeBio Oncology Therapeutics
M$64.27
0
+M$3.23+5.29%Friday 18:29
Statistics
Day High
64.27
Day Low
64.27
52W High
64.27
52W Low
61.04
Volume
-
Avg. Volume
-
Mkt Cap
5.15B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 18Expected
Q2 2026
Next
-12.86
-11.79
-10.71
-9.64
Expected EPS
-12.8589285999
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BBOT.MX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Show More
CEO
Pedro J. Beltran
Employees
88
Country
Cayman Islands
ISIN
US1079241022
Listings
0 Comments
Share your thoughts
FAQs
What is BridgeBio Oncology Therapeutics stock price today?▼
The current price of BBOT.MX is M$64.27 MXN — it has increased by +5.29% in the past 24 hours. Watch BridgeBio Oncology Therapeutics stock price performance more closely on the chart.
What is BridgeBio Oncology Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange BridgeBio Oncology Therapeutics stocks are traded under the ticker BBOT.MX.
What is BridgeBio Oncology Therapeutics market cap?▼
Today BridgeBio Oncology Therapeutics has the market capitalization of 5.15B
When is the next BridgeBio Oncology Therapeutics earnings date?▼
BridgeBio Oncology Therapeutics is going to release the next earnings report on November 18, 2026.
What were BridgeBio Oncology Therapeutics earnings last quarter?▼
BBOT.MX earnings for the last quarter are -12.03 MXN per share, whereas the estimation was -9.64 MXN resulting in a -24.81% surprise. The estimated earnings for the next quarter are N/A MXN per share.
How many employees does BridgeBio Oncology Therapeutics have?▼
As of October 11, 2026, the company has 88 employees.
In which sector is BridgeBio Oncology Therapeutics located?▼
BridgeBio Oncology Therapeutics operates in the Health & Wellness sector.
When did BridgeBio Oncology Therapeutics complete a stock split?▼
BridgeBio Oncology Therapeutics has not had any recent stock splits.
Where is BridgeBio Oncology Therapeutics headquartered?▼
BridgeBio Oncology Therapeutics is headquartered in SOUTH SAN FRANCISCO, Cayman Islands.